SANTOS HELENA R 4

What Happened Helena R. Santos, President, CEO and a director of Scientific Industries, received a grant of 50,000 derivative awards (options) on February 17, 2026. The filing shows the transaction as an acquisition (award/grant) of a derivative instrument; no exercise price or total dollar value is reported (N/A).

Key Details

• Transaction date: 2026-02-17; Form 4 filed: 2026-04-01 (filed late relative to the usual 2-business-day deadline).
• Shares/options granted: 50,000 (derivative award). Price/value: not disclosed (N/A).
• Shares owned after transaction: not reported in the provided filing details.
• Footnote: Options were granted in lieu of salary. Vesting: 1 year total, vesting 1/12th per month (monthly vesting over one year).

Context This was a compensation grant (options issued to the executive), not an open-market purchase or sale. Such awards are common as part of executive pay and do not by themselves signal an immediate buying or selling view. Because the grant’s price/value wasn’t disclosed and the Form 4 was filed late, investors should watch future filings for vesting, any exercises or sales, and the company’s disclosures for potential dilution.